logo
Select company
Select metric
$ -10.96MNet Cash Flow - Operations
VS
Market
21
Sector
54
Industry
76
History
50
$ 2.52Close
$ 2.36 - $ 27 52-Week Range
Ticker Information

Ticker

AIM

Company Name

AIM IMMUNOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

AIM IMMUNOTECH INC - Net Cash Flow - Operations Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AIM - CF - Operations Historical data
DateNet Cash Flow - Operations
6/30/2025$ -10.96M
3/31/2025$ -12.43M
12/31/2024$ -14.89M
9/30/2024$ -20.69M
6/30/2024$ -23.25M
3/31/2024$ -22.4M
12/31/2023$ -21.27M
9/30/2023$ -17.58M
6/30/2023$ -16.88M
3/31/2023$ -17.03M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AIM IMMUNOTECH INC's latest trailing twelve months (TTM) CF - Operations stands at $ -9.8M.
  • Over the past 5 years, AIM IMMUNOTECH INC's average CF - Operations has been $ -15.17M.
  • The median CF - Operations for AIM IMMUNOTECH INC during this period was $ -14.58M
  • AIM IMMUNOTECH INC reached its highest CF - Operations over the past 5 years at $ -9.8M.
  • The lowest CF - Operations recorded by AIM IMMUNOTECH INC in the same timeframe $ -23.25M

AIM IMMUNOTECH INC's CF - Operations vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Operations Benchmarks
CompanyCF - Operations
SILO : SILO PHARMA INC $ -5.19MVIVS : VIVOSIM LABS INC $ -10.42MHCWB : HCW BIOLOGICS INC $ -12.56MCDIO : CARDIO DIAGNOSTICS HOLDINGS INC $ -5.52MIBO : IMPACT BIOMEDICAL INC $ -3.92MPMCB : PHARMACYTE BIOTECH INC $ -4.6MAPVO : APTEVO THERAPEUTICS INC $ -24.65MACXP : ACURX PHARMACEUTICALS INC $ -8.16MPALI : PALISADE BIO INC $ -9.66MGNPX : GENPREX INC $ -14.08M

Definition of Net Cash Flow - Operations

[Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.

AIM - Net Cash Flow - Operations, Last 5 years

$ -23.25M

Minimum

Jun 30, 2024

$ -9.8M

Maximum

Sep 30, 2020

$ -15.17M

Average

$ -14.58M

Median

CF - Operations Benchmark Analysis

The chart above depicts the distribution of CF - Operations for companies in the Total Stock Market. The average CF - Operations of the companies is $ 58.3M with a standard deviation of $ 142.13M.
The following table provides additional summary stats:
CF - Operations in the Market:
filtered constituents3.26K
min$ -406M
max$ 508.1M
average$ 58.3M
median$ 10.91M
std$ 142.13M